Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?

Overview of attention for article published in BMC Cancer, February 2017

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 1,074 followers.

Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via... https://t.co/wdVS0yJjMH

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.